Podcast

Podcast: This Week in Managed Care—Tracking Drug Price Hikes and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included the Institute for Clinical and Economic Review investigating rising drug prices; CMS expanding value-based insurance design; and researchers using a blood test to detect preclinical Alzheimer disease.

You may need to log in to the website to access this podcast.

iTunes

TuneIn

Stitcher

Listen above or through one of these podcast services:

What's Driving US Healthcare Costs? Stakeholders Weigh In

ICER Will Review If Drug Price Hikes Are Supported by New Evidence

Report: Increasing Drug Prices, Shortages Causing Hospitals to Cut Staff, Putting Patient Safety at Risk

What We're Reading: Insulin Costs Double; PhRMA's Record Spending; Causes of Liver Transplants

CMS Expands VBID in Medicare Advantage, Increases Risk Sharing in Part D

Researchers Use Blood Test to Detect Preclinical Alzheimer Disease Signs

Improving Care for Patients With Metastatic Breast Cancer

Read more about the stories in this podcast:

Related Videos
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Dr Andrew S. Oseran
Dr Andrew S. Oseran
Dr Maria DeYoreo
Dr Maria DeYoreo
Dr Maria DeYoreo
dr carol regueiro
Related Content
AJMC
April 2nd 2025

Prior Authorizations and the Adverse Impact on Continuity of Care

Jay S. Pickern, DBA
Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Medicare Part D graphic | Image Credit: driftwood - stock.adobe.com
March 24th 2025

Medicare $2 Drug List Model Could Have Reduced 2021 Out-of-Pocket Generic Costs

Brooke McCormick
The researchers emphasized the need for ongoing research and advocacy to further address drug affordability.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Document with "denied" | Image Credit: © G_stockerthailand - stock.adobe.com
March 18th 2025

How Access to SMA Treatment Varies Globally and by Insurance Type

Christina Mattina
Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Health care costs - Valeri Luzina - stock.adobe.com
March 14th 2025

The Impact of Cost Sharing on High-Value Care

Pearl Steinzor
Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo